Drug interactions
Imiglucerase + Miglustat
Severity: Minor
Imiglucerase and Miglustat: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both drugs treat Gaucher disease and may be combined, but one small study suggested lower exposure to imiglucerase with miglustat. The data are inconclusive and the clinical consequence is uncertain.
What this interaction means in plain words
Imiglucerase and Miglustat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Imiglucerase belongs to Miscellaneous; Miglustat belongs to Miscellaneous.
Why it happens
The mechanism is not established; increased imiglucerase clearance was suggested.
What to do
Monitor clinical and biochemical response of Gaucher disease, such as hemoglobin, platelets and spleen size, and adjust enzyme dosing if response is inadequate.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Imiglucerase and Miglustat, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Frequently asked questions
Can I take Imiglucerase with Miglustat?
MediHelp rates the interaction as minor. Imiglucerase and Miglustat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Both drugs treat Gaucher disease and may be combined, but one small study suggested lower exposure to imiglucerase with miglustat. The data are inconclusive and the clinical consequence is uncertain.
How serious is the interaction between Imiglucerase and Miglustat?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical and biochemical response of Gaucher disease, such as hemoglobin, platelets and spleen size, and adjust enzyme dosing if response is inadequate.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
